Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,609
Total Claims
$845K
Drug Cost
1,112
Beneficiaries
$760
Cost/Patient
Risk Score Breakdown 56/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
+689%
Opioid rate vs peers
72.5% vs 9.2% avg
+6%
Cost per patient vs peers
$760 vs $719 avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid prescribing rate is 689% above the average for Physician Assistant providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Composite risk score of 56/100 places this provider in the "High Risk" category — the top 0.017% of all Medicare Part D prescribers. Multiple independent risk factors are contributing simultaneously.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
72.5%
Opioid Rate
7,691
Opioid Claims
$666K
Opioid Cost
17.8%
Long-Acting Rate
This provider's opioid prescribing rate of 72.5% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 706 claims · $390K
Generic: 9,903 claims · $455K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Myristate | 181 | $123K |
| Hydrocodone/Acetaminophen | 2,355 | $82K |
| Buprenorphine Hcl | 102 | $81K |
| Oxycodone Hcl | 2,037 | $62K |
| Oxycodone Hcl/Acetaminophen | 13 | $61K |
| Oxycodone Hcl/Acetaminophen | 1,272 | $57K |
| Oxycodone Hcl | 103 | $56K |
| Rimegepant Sulfate | 22 | $50K |
| Fentanyl | 276 | $40K |
| Buprenorphine | 86 | $30K |
| Oxymorphone Hcl | 16 | $24K |
| Gabapentin | 927 | $19K |
| Erenumab-Aooe | 12 | $16K |
| Morphine Sulfate | 420 | $15K |
| Pregabalin | 279 | $13K |
Prescribing Profile
48
Unique Drugs
56.0
Anomaly Score
Patient Profile
65
Avg Age
62%
Female
1.60
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data